Optilume BPH catheter system for enlarged prostate symptoms
Part of Kidney & urinary clinical trials.
This trial tests a device called Optilume BPH Catheter System for men with enlarged prostate that causes bothersome urinary symptoms. It aims to see how safe and effective it is in real-world use, offering a possible treatment for blocked urine flow without surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 50 or older.
- You have symptoms like frequent or difficult urination due to an enlarged prostate.
- Your prostate size on ultrasound is less than 80 grams and the length of your urine channel inside is between 32-55 mm.
- Your symptom score is at least 13 (moderate to severe), and your peak urine flow rate is between 5-15 mL per second.
- You have not had any prior treatments for enlarged prostate like UroLift, Rezūm, or surgery.
- You can use condoms for 30 days after the procedure and your partner must use effective birth control for 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the Omega System is safe and effective for improving symptoms from an enlarged prostate (BPH). It looks for men with bothersome urine symptoms and certain prostate size/flow measurements, while carefully excluding prostate cancer and other conditions that could interfere or be unsafe.
This trial studies a device called the Omega System to see if it is safe and effective for urinary problems caused by an enlarged prostate (BPH). You may be a better fit if you have moderate-to-severe symptoms and prostate measurements that match the study plan, and if you are scheduled for prostate surgery or need evaluation for BPH.
This trial tests a new device called the FloStent, a small tube placed in the urine channel to help men with an enlarged prostate pee more easily. It's for men who have moderate to severe symptoms and haven't had prostate surgery before.
This trial compares two laser treatments for an enlarged prostate (benign prostatic hyperplasia, or BPH) in men whose symptoms did not improve with medicine. It may help find which laser approach works better for improving urine flow and symptom relief.
This study tests a new device called the Steep Pulse Therapy System that uses short electrical pulses to destroy extra prostate tissue without cutting. It is for men with moderate to severe BPH symptoms who have not had prior prostate surgery.
This study tests a new device (Vivifi) that aims to treat an enlarged prostate without surgery. The goal is to improve urine flow and reduce symptoms like frequent or weak urination.
Hear when a new Benign Prostatic Hyperplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.